NASDAQ:GEVA (GEVA) (GEVA) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free GEVA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (GEVA) alerts: Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About (GEVA) Stock (NASDAQ:GEVA)Synageva BioPharma Corp. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products for the treatment of rare diseases. The Company has a pipeline of protein therapeutic programs for rare diseases. Its lead product is Kanuma (sebelipase alfa) being developed for the treatment of lysosomal acid lipase deficiency (LAL Deficiency). The Company’s other product candidates under development include SBC-103, a first-mover enzyme replacement therapy program for mucopolysaccharidosis IIIB (MPS IIIB, also known as Sanfilippo B syndrome) and SBC-105, which is a first-mover enzyme therapy in preclinical development for rare disorders of calcification, including the indication generalized calcification in infants (GACI). The Company also has additional first-mover and potentially bio-superior protein therapeutic pipeline programs for other rare diseases at different stages of preclinical development.Read More Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… GEVA Stock News HeadlinesMarch 27, 2024 | msn.com'Consistency and composure' needed of Leeds Rhinos Netball or season will be over, warns Liana LeotaMarch 27, 2024 | msn.comGeva Theatre reveals line-up for the 2024/2025 seasonMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 26, 2024 | msn.comArab citizens of Israel: Between repression and hopeMarch 25, 2024 | msn.comGeva Theatre announces 2024-25 season lineupMarch 25, 2024 | msn.comLarge language models use a surprisingly simple mechanism to retrieve some stored knowledgeMarch 22, 2024 | msn.comLeeds Rhinos Netball need to play to Joyce Mvula's strengths more, says Liana LeotaMarch 22, 2024 | msn.comGeva Theatre invites the public to 2024-25 season unveilingMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 16, 2024 | bbc.comWatch: Netball Super League - Loughborough Lightning v Leeds RhinosMarch 15, 2024 | msn.comLeeds Rhinos Netball see Loughborough Lightning as a test of how far they've comeMarch 9, 2024 | bbc.co.ukSurrey Storm v Cardiff DragonsMarch 9, 2024 | bbc.comWatch: Netball Super League - Surrey Storm v Cardiff DragonsMarch 8, 2024 | msn.com'Excuse Me for Descending on You as Shabbat Ends. My 80-year-old Father-in-law Is in Gaza Now'March 7, 2024 | msn.comClassifying quantum secrets: Pendulum experiment reveals insights into topological materialsFebruary 24, 2024 | bbc.co.ukWatch: Netball Super League - Loughborough Lightning v Team BathFebruary 20, 2024 | msn.comGeva Theatre recounts the life of Jazz legend Billie Holiday in upcoming productionFebruary 18, 2024 | mirror.co.ukNetball legend makes bold vow after unexpected return to the English gameFebruary 18, 2024 | msn.comGeva Mentor upstaged as Leeds Rhinos fall flat in Netball Superleague openerFebruary 16, 2024 | msn.com'I didn't want to go teetotal' - Mentor on returnFebruary 16, 2024 | msn.comNetball legend Geva Mentor setting lofty goals on return to UKFebruary 15, 2024 | bbc.comNetball Super League 2024: Geva Mentor on returning to Super LeagueFebruary 9, 2024 | msn.comWhy SA's networks need to defend against the devastating effect of SIM swap fraudFebruary 3, 2024 | msn.comVeteran guitarist, vocalist Amir Lev returns to an old favoriteJanuary 27, 2024 | msn.comGeva Mentor interview: England Roses retirement, Leeds Rhinos opportunity and netball's need for Commonwealth Games to stay aliveJanuary 23, 2024 | businesswire.comAs part of its expanding activities in the United States of America: Israel Aerospace Industries (IAI) Announces Launch of U.S. Innovation Center and Unveils Debut Program, IAI ...January 18, 2024 | tmcnet.comHow Payback Ltd Reimbursed Over $5,000,000 To Victims Of Financial Fraud in 2023See More Headlines Receive GEVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (GEVA) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/26/2015Today3/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryBiotechnology Current SymbolNASDAQ:GEVA CUSIP87159A10 CIK911326 Webwww.synageva.com Phone+1-781-3579900FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report GEVA Stock Analysis - Frequently Asked Questions How were (GEVA)'s earnings last quarter? (GEVA) (NASDAQ:GEVA) issued its quarterly earnings data on Thursday, February, 26th. The biopharmaceutical company reported ($1.73) earnings per share for the quarter, missing the consensus estimate of ($1.71) by $0.02. The biopharmaceutical company earned $1.24 million during the quarter, compared to the consensus estimate of $1.25 million. What other stocks do shareholders of (GEVA) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (GEVA) investors own include AutoZone (AZO), Intuitive Surgical (ISRG), U-Haul (UHAL), Regeneron Pharmaceuticals (REGN), Netflix (NFLX), AT&T (T), Novavax (NVAX), Ur-Energy (URG), Biogen (BIIB) and BioMarin Pharmaceutical (BMRN). This page (NASDAQ:GEVA) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryFed launches fourth dollar overhaulStansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubThe 3rd Revolution in WarfareWeiss RatingsBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (GEVA) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.